Reimbursing Patients for Participation in Cancer Clinical Trials
This Viewpoint describes the potential benefits associated with reimbursing patients for participation in cancer clinical trials.
Related Articles
Promising Top-Line Results for RSV Vaccine in Immunocompromised Adults
Pfizer’s ABRYSVO vaccine was safe and generated a strong immune response against respiratory syncytial virus (RSV) in immunocompromised adults aged 18 years or older, according…
FDA Fast-Tracks First Nasal Spray for Allergic Reactions, Anaphylaxis
The US Food and Drug Administration (FDA) recently approved neffy, an epinephrine nasal spray, to treat emergency allergic reactions, including anaphylaxis. The spray is the…
Multiple Onychopapillomas and BAP1 Tumor Predisposition Syndrome
This cohort study investigates nail abnormality prevalence among patients with (BRCA1-associated protein) BAP1 tumor predisposition syndrome.
Tumor-Infiltrating Lymphocytes in Stage I TNBC Untreated With Chemotherapy
This cohort study examines the association between the presence of stromal tumor-infiltrating lymphocytes and survival among patients with stage I triple-negative breast cancer (TNBC) for…
Intraocular Pressure Outcomes After Lampalizumab Injections in Patients With Geographic Atrophy
This post hoc analysis of a randomized clinical trial investigates intraocular pressure outcomes after 1 year of repeated 0.1-mL intravitreous injections by analyzing data from…
Prehospital Pulse-Dose Glucocorticoid in STEMI
This randomized clinical trial investigates if prehospital pulse-dose glucocorticoid treatment has a cardioprotective effect in patients with ST-segment elevation myocardial infarction (STEMI).
Adjuvant Psychotherapies to Prevent Relapse in Bipolar Disorder
This randomized clinical trial investigates the effectiveness of skill-oriented, material-based cognitive behavioral therapy (SEKT) and supportive, patient-centered, emotion-focused therapy (FEST) forms of psychotherapy in the…
GLP-1 Receptor Agonist Use and Risk of Suicide Death
This cohort study assesses the association between use of glucagon-like peptide-1 receptor agonists and the risk of suicide death in routine clinical practice.
European Respiratory Society International Congress
Explore special articles published online first to coincide with presentations at the European Respiratory Society International Congress.
European Respiratory Society International Congress
Explore special articles published online first to coincide with presentations at the European Respiratory Society International Congress.
